Cargando…

A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies

SARS-CoV-2, the cause of the COVID-19 pandemic, has provoked a global crisis and death of millions of people. Several serological assays to determine the quality of the immune response against SARS-CoV-2 and the efficacy of vaccines have been developed, among them the gold standard conventional viru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pi-Estopiñan, Franciscary, Pérez, María Teresa, Fraga, Anitza, Bergado, Gretchen, Díaz, Geidy D., Orosa, Ivette, Díaz, Marianniz, Solozábal, Joaquín Antonio, Rodríguez, Laura Marta, Garcia-Rivera, Dagmar, Macías, Consuelo, Jerez, Yanet, Casadesús, Ana V., Fernández-Marrero, Briandy, Bermúdez, Ernesto, Plasencia, Claudia A., Sánchez, Belinda, Hernández, Tays
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856731/ https://www.ncbi.nlm.nih.gov/pubmed/35193792 http://dx.doi.org/10.1016/j.vaccine.2022.02.044

Ejemplares similares

A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles
por: Santana-Mederos, Darielys, et al.
Publicado: (2021)

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
por: Pérez-Rodríguez, Sonia, et al.
Publicado: (2022)

Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy
por: Casadesús, Ana Victoria, et al.
Publicado: (2022)

Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial
por: Ochoa-Azze, Rolando, et al.
Publicado: (2022)

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
por: Eugenia-Toledo-Romaní, María, et al.
Publicado: (2022)

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
por: Chang-Monteagudo, Arturo, et al.
Publicado: (2021)

Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
por: Villafañe, Luciana, et al.
Publicado: (2022)

Elevated Humoral Immune Response to SARS-CoV-2 at High Altitudes Revealed by an Anti-RBD “In-House” ELISA
por: Tomas-Grau, Rodrigo Hernán, et al.
Publicado: (2021)

Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein
por: Rodríguez, María Celeste, et al.
Publicado: (2022)

RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers
por: Aguilar, Ruth, et al.
Publicado: (2023)

Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens
por: Boggiano-Ayo, Tammy, et al.
Publicado: (2023)

A Low-Cost SARS-CoV-2 rRBD ELISA to Detect Serostatus in Ecuadorian Population with COVID-19
por: Guevara, Ángel, et al.
Publicado: (2021)

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022)

Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings
por: Benabdessalem, Chaouki, et al.
Publicado: (2023)

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies
por: Bergado-Báez, Gretchen, et al.
Publicado: (2022)

Breve historia de Yucatán : (edición especial para la enseñanza preparatoria)
por: Orosa Díaz, Jaime
Publicado: (1981)

Picheta
por: Orosa Díaz, Jaime
Publicado: (1948)

Felipe Carrillo Puerto : estudio biográfico /
por: Orosa Díaz, Jaime
Publicado: (1982)

Los jovenes, el periodismo y la literatura
por: Orosa Díaz, Jaime
Publicado: (1977)

Nombres en las letras y en la vida
por: Orosa Díaz, Jaime
Publicado: (1975)

Pensamiento político de Hidalgo y de Morelos y otros temas
por: Orosa Díaz, Jaime
Publicado: (1976)

Se vende un hombre : farsa en tres cuadros
por: Orosa Díaz, Jaime
Publicado: (1974)

Yucatán : panorama histórico, geográfico y cultural
por: Orosa Díaz, Jaime
Publicado: (1945)

Legislación henequera en Yucatán (1833 - 1955)
por: Orosa Díaz, Jaime
Publicado: (1956)

Compendio de Historia de Yucatán : para uso de las escuelas primarias del estado
por: Orosa Díaz, Jaime
Publicado: (1958)

Ensayo sobre la Revolución Mexicana
por: Orosa Díaz, Jaime
Publicado: (1963)

Cultura mexicana; apuntes sobre sus orígenes y carácteres
por: Orosa Díaz, Jaime
Publicado: (1969)

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
por: Toledo-Romani, María Eugenia, et al.
Publicado: (2022)

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
por: Fu, Wenyu, et al.
Publicado: (2020)

Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins
por: Yilmaz, Aysun, et al.
Publicado: (2022)

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Development of a Multispecies Double-Antigen Sandwich ELISA Using N and RBD Proteins to Detect Antibodies against SARS-CoV-2
por: Cordero-Ortiz, Maritza, et al.
Publicado: (2023)

Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials
por: Blanco, Omar R., et al.
Publicado: (2022)

Influence of Microstructural Defects on the Martensitic Transformation and on the Magnetic Properties of Ni-based Heusler Alloys
por: Unzueta Solozabal, Iraultza
Publicado: (2019)

Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds
por: Padoan, Andrea, et al.
Publicado: (2022)

Enfermedades de repercusión ganglionar/
por: Díaz Córdoba, Araceli Yanet
Publicado: (1993)

The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases
por: Cama, Viviana Falcón, et al.
Publicado: (2021)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8q9t9fk52ap25fgbrseid24e6r